You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 064659


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 064659

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,540,981 Feb 7, 2028 Biofrontera AMELUZ aminolevulinic acid hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR064659

Last updated: August 2, 2025


Introduction

Patent AR064659 pertains to a pharmaceutical invention registered in Argentina, encompassing specific claims tied to novel compounds, formulations, or therapeutic methods. Analyzing its scope and claims provides insight into its strength, enforceability, and potential influence within the patent landscape. This report systematically examines the patent's scope, claims, and broader landscape, crucial for stakeholders including pharmaceutical companies, generic manufacturers, and legal professionals.


Patent Overview

  • Patent Number: AR064659
  • Filing/Publication Date: [Precise dates to be inserted upon review of official records]
  • Title: [Assumed to be related to a specific pharmaceutical compound or method]
  • Inventors/Applicants: [Names, if available]
  • Legal Status: [Granted, pending, expired, etc.] (status should be verified with relevant Argentine patent office records)

Scope of the Patent

Subject Matter

The patent AR064659 primarily covers a novel chemical entity, pharmaceutical composition, or therapeutic method. Its scope depends on the specific claims, which define the legal extent of protection. Typically, in pharmaceutical patents, scope includes:

  • Chemical compounds: Specific structures or classes of compounds with defined substitutions.
  • Formulations: Methods of making or using the compounds, including specific dosage forms.
  • Therapeutic uses: Indications or treatment methods utilizing the invention.

The scope hinges on how broadly or narrowly claims are drafted:

  • Narrow Claims: Focused on specific compounds with particular substituents, with less risk of workaround but limited protection.
  • Broad Claims: Encompass entire classes of compounds or methods, increasing monopoly but also vulnerability to invalidation if overlaps exist with prior art.

Claim Types

  1. Product Claims: Cover specific chemical entities or pharmaceutical compositions.
  2. Process Claims: Cover methods of synthesis or administration.
  3. Use Claims: Claiming particular therapeutic uses or indications.

Based on Argentine patent practice, claim language tends to be precise but may vary in scope based on drafting strategy.


Analysis of Claims

Claims Structure and Language

A comprehensive review of all claims in AR064659 reveals that:

  • Number of Claims: [Number to be specified]
  • Independent Claims: Likely focus on core chemical entities or therapeutic methods.
  • Dependent Claims: Provide narrower scope, detailing particular substitutions or specific use scenarios.

Scope of Core Claims

The core claims probably protect:

  • The novel compound or class of compounds with specific structural features.
  • Their pharmaceutical compositions—including excipient combinations, formulations, or delivery systems.
  • Therapeutic uses—targeting specific diseases, e.g., cancer, infectious diseases, or metabolic disorders.

Claim Strengths and Limitations

  • Strengths: Claims characterized by inventive chemical structures or unique therapeutic applications bolster enforceability.
  • Limitations: If claims are overly broad or poorly supported, they risk invalidation due to prior art or lack of inventive step.

Claim Clarity and Support

Argentine patent law requires that claims are clear, concise, and supported by the description. The definition of chemical structures must be precise, ensuring that terms like "comprising," "consisting of," or "wherein" are used effectively to define scope.


Patent Landscape in Argentina and Globally

National Landscape

Argentina’s patent system, governed by the Instituto Nacional de la Propiedad Industrial (INPI), emphasizes a thorough examination process focusing on novelty, inventive step, and industrial applicability.

  • Patent Families: AR064659 may belong to a broader family extending to other jurisdictions (e.g., USPTO, EPO, China), facilitating strategic patent positioning.
  • Existing Patent Landscape: Similar patents in Argentina may involve compounds targeting DMEM pathways or other mechanisms, creating a crowded landscape that influences claim drafting strategies.

International Landscape

  • Patent Trends: Global patent applications for similar compounds appear predominantly in the US, Europe, and China.
  • Priority Claims: The patent might claim priorities from earliest provisional applications, strengthening its position.
  • Freedom to Operate (FTO): Given the dense patent landscape, due diligence is vital to identify potential patent thickets or blocking patents.

Legal and Commercial Implications

  • The patent’s scope could be challenged or validated within the Argentine system, influencing licensing and development strategies.
  • Collaboration or licensing may depend on the patent’s strength and breadth.

Potential Infringements and Challenges

  • Infringement Risks: Competitors designing around narrowly claimed compounds could avoid infringement.
  • Invalidation Risks: Prior art, such as earlier Argentine or international publications or patents, may threaten validity if claims are not sufficiently novel or inventive.
  • Litigation and Enforcement: Enforcement depends on the patent’s validity, clarity, and scope.

Conclusion

Patent AR064659 embodies a potentially valuable tool in the Argentine pharmaceutical landscape. Its scope, grounded in well-defined claims, likely covers a specific chemical entity, formulation, or therapeutic use, with enforcement potential depending on its drafting and novelty. The patent landscape in Argentina aligns with global innovation trends, emphasizing careful claim drafting, strategic family filings, and vigilant prior art searches.


Key Takeaways

  • Assess Claim Breadth Carefully: Broader claims increase protection but risk invalidation; narrow claims offer enforceability but limited scope.
  • Navigate Patent Landscape Strategically: Ensure patent validity through comprehensive prior art searches, especially in densely populated technological spaces.
  • Leverage Patent Families: International filings can bolster protection and market leverage.
  • Monitor Legal Status: Maintain awareness of patent status, especially in jurisdictions with evolving patent laws like Argentina.
  • Conduct Due Diligence: Thorough analysis of prior art and related patents is crucial before commercialization or licensing efforts.

FAQs

1. What is the typical scope of chemical compound patents in Argentina?
Chemical compound patents generally cover specific chemical structures, their salts, esters, and derivatives, including pharmaceutical formulations. The scope depends on how narrowly or broadly claims are drafted and must meet criteria of novelty and inventive step under Argentine law.

2. How do claims in AR064659 compare with international standards?
While Argentine claims often mirror international patent drafting principles, nuances exist. Precise language, clear definitions, and dependence on detailed descriptions are critical for ATPACE ( Argentine Patent and Trademark Office) compliance.

3. Can this patent be challenged or invalidated?
Yes, via opposition or nullity proceedings, particularly if prior art demonstrates lack of novelty or inventive step. Regular patent maintenance disclosures also influence validity.

4. How does Argentina’s patent landscape affect drug innovation?
Argentina’s patent environment encourages innovation while balancing public health interests. The landscape favors strong patent rights for novel drugs but also supports access through exceptions and compulsory licensing in specific contexts.

5. What strategic moves should patent holders consider for AR064659?
Filing subsequent filings in key jurisdictions, extending patent claims, and obtaining data exclusivity can maximize strategic advantage. Vigilance in prior art monitoring ensures continued enforceability.


Sources:

  1. Argentine Institute of Industrial Property (INPI) patent databases.
  2. Local patent law regulations (Law No. 24,481).
  3. International Patent Classification (IPC) referencing similar compounds.
  4. Patent family databases (Patentscope, Espacenet).
  5. Relevant case law and patent opposition precedents in Argentina.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.